Cargando…

Dupilumab Improves Pruritus in Netherton Syndrome: A Case Study

The patient was a 26-year-old male. He had red and scaling skin of the entire body since birth, as well as an elevated level of serum IgE. Genetic testing revealed a mutation in the SPINK5 gene, which had confirmed the diagnosis with Netherton syndrome. He has had significant pruritis since birth, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inaba, Yutaka, Kanazawa, Nobuo, Muraoka, Kyoko, Yariyama, Azusa, Kawaguchi, Ami, Kunimoto, Kayo, Kaminaka, Chikako, Yamamoto, Yuki, Tsujioka, Kaoru, Yoshida, Akira, Yanagi, Teruki, Jinnin, Masatoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946880/ https://www.ncbi.nlm.nih.gov/pubmed/35327681 http://dx.doi.org/10.3390/children9030310

Ejemplares similares

Report of two sisters with Netherton syndrome successfully treated with dupilumab and review of the literature
por: Martin-García, Cristina, et al.
Publicado: (2023)

ISSVA Classification of Vascular Anomalies and Molecular Biology
por: Kunimoto, Kayo, et al.
Publicado: (2022)

Dupilumab for cancer-associated refractory pruritus
por: Talmon, Aviv, et al.
Publicado: (2023)

Dupilumab improves clinical symptoms in children with Netherton syndrome by suppressing Th2-mediated inflammation
por: Yan, Shi, et al.
Publicado: (2022)

Treatment Experiences with Intravenous Immunoglobulins, Ixekizumab, Dupilumab, and Anakinra in Netherton Syndrome: A Case Series
por: Ragamin, Aviël, et al.
Publicado: (2023)

Recalcitrant anal and genital pruritus treated with dupilumab()()()()
por: Yang, E.J., et al.
Publicado: (2018)

The use of dupilumab for the treatment of recalcitrant brachioradial pruritus
por: Abel, Mary Kathryn, et al.
Publicado: (2021)

Dupilumab Failure in Treating Dermatomyositis-Associated Pruritus
por: O'Brien, Margaret A, et al.
Publicado: (2022)

Chronic Pruritus Responding to Dupilumab—A Case Series
por: Zhai, Lisa L., et al.
Publicado: (2019)

A successful case of dupilumab treatment for severe uremic pruritus
por: Silverberg, Jonathan I., et al.
Publicado: (2019)

Bamboo Hair in Netherton's Syndrome
por: Salodkar, Atul D, et al.
Publicado: (2009)

Netherton Syndrome with Pili Torti
por: Srinivas, Sahana M, et al.
Publicado: (2013)

Refractory pruritus responds to dupilumab in a patient with TTC7A mutation
por: Alipour Tehrany, Yassaman, et al.
Publicado: (2020)

Netherton syndrome: A rare genodermatosis
por: Dey, Vivek Kumar
Publicado: (2011)

A Case Report on Netherton Syndrome
por: Abdalrheem, Wiel O, et al.
Publicado: (2020)

Successful use of secukinumab in Netherton syndrome
por: Blanchard, Sarah K., et al.
Publicado: (2020)

Biological treatments for pediatric Netherton syndrome
por: Pontone, Matteo, et al.
Publicado: (2022)

Severe Hypernatremia as Presentation of Netherton Syndrome
por: Di Nora, A., et al.
Publicado: (2023)

Bilateral Eyebrow Sclerosis: A New Clinical Entity
por: Ueno, Kazuki, et al.
Publicado: (2020)

Six cases of refractory pruritus and histologic dermal hypersensitivity reaction successfully treated with dupilumab
por: Edmonds, Nicole, et al.
Publicado: (2021)

Upadacitinib as a treatment for chronic pruritus secondary to polycythemia vera after failure with dupilumab
por: Wachuku, Christopher I., et al.
Publicado: (2023)

Effects of low‐dose Aloe sterol supplementation on skin moisture, collagen score and objective or subjective symptoms: 12‐week, double‐blind, randomized controlled trial
por: Kaminaka, Chikako, et al.
Publicado: (2020)

Saliva contact during infancy and allergy development in school-age children
por: Kubo, Yoshimi, et al.
Publicado: (2023)

Long-term Remission of Atopic Dermatitis after Discontinuation of Dupilumab
por: MIYAMOTO, Shoko, et al.
Publicado: (2022)

Trichorrhexis invaginata and ichthyosiform erythroderma in netherton syndrome
por: Ahmadian Heris, Javad, et al.
Publicado: (2021)

Skin Microbiota and Clinical Associations in Netherton Syndrome
por: Sillanpää, Veera, et al.
Publicado: (2021)

Netherton Syndrome in Children: Management and Future Perspectives
por: Barbati, Federica, et al.
Publicado: (2021)

Dupilumab induces a rapid decrease of pruritus in adolescents: A pilot real‐life study
por: Mastorino, Luca, et al.
Publicado: (2021)

Immunoglobulin G4-Related Disease-Associated Dermatitis with Pruritus: A Positive Response to Dupilumab
por: Beck, Tyler C., et al.
Publicado: (2023)

Baricitinib rapidly and sustainably relieves a patient from chronic pruritus of unknown origin refractory to dupilumab
por: Buttgereit, Thomas, et al.
Publicado: (2021)

Chronic Pruritus in Atopic Patients Treated with Dupilumab: Real Life Response and Related Parameters in 354 Patients
por: Mastorino, Luca, et al.
Publicado: (2022)

Rapid resolution of widespread cutaneous lichen planus and generalized pruritus in an elderly patient following treatment with dupilumab
por: Kazemi, Soroush, et al.
Publicado: (2022)

Netherton Syndrome, a Case Report and Review of Literature
por: Boskabadi, Hassan, et al.
Publicado: (2013)

Infliximab therapy for Netherton syndrome: A case report
por: Roda, Ângela, et al.
Publicado: (2017)

Immune cell phenotype and functional defects in Netherton syndrome
por: Eränkö, Elina, et al.
Publicado: (2018)

Netherton Syndrome: A Case Report and Review of Literature
por: Saleem, Hafiz M. Kashif, et al.
Publicado: (2018)

Oral Tofacitinib Therapy for the Effective Management of Netherton Syndrome
por: Dodeja, Ajay, et al.
Publicado: (2023)

Exploration of Metabolite Biomarkers to Predict the Efficacy of Dupilumab Treatment for Atopic Dermatitis
por: Miyamoto, Shoko, et al.
Publicado: (2023)

Trichoscopy as a diagnostic tool in trichorrhexis invaginata and Netherton syndrome()
por: Bittencourt, Maraya de Jesus Semblano, et al.
Publicado: (2015)

KLK5 Inactivation Reverses Cutaneous Hallmarks of Netherton Syndrome
por: Furio, Laetitia, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_39e8nnvn7d5qfmpjjkdpmhs82m